Approval · Notice of Compliance 4477 · 1996
WELLFERON: Notice of Compliance 4477
Issued September 9, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4477
- Date
- September 9, 1996
- Company
- Glaxo Wellcome Inc.Mississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Biological response modifier
Products in this notice
Medicinal ingredients
- INTERFERON ALPHA-N1 (INS) 3,000,000 UNIT per ML
- INTERFERON ALPHA-N1 (INS) 5,000,000 UNIT per ML
- INTERFERON ALPHA-N1 (INS) 10,000,000 UNIT per ML